Dominik Paul Modest (D P Modest, Dominik P Modest)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Metastatic Colorectal Cancer

Mesenchymal Stem Cells

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

International journal of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Arndt Stahler, Andreas Jay Kind, Christine Sers, Soulafa Mamlouk, Lothar Müller, Meinolf Karthaus, Stefan Fruehauf, Ullrich Graeven, Ludwig Fischer von Weikersthal, Greta Sommerhäuser, Stefan Kasper, Beeke Hoppe, Annika Kurreck, Swantje Held, Volker Heinemann, David Horst, Armin Jarosch, Sebastian Stinzing, Tanja Trarbach, Dominik Paul Modest
Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212). Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Thomas Jens Ettrich, Dominik Paul Modest, Marianne Sinn, Jana K Striefler, Bernhard Opitz, Thorsten Goetze, Eike Gallmeier, Stefan Angermeier, Ludwig Fischer von Weikersthal, Lutz Jacobasch, Dirk Waldschmidt, Michael Niedermeier, Michael Sohm, Andreas W Berger, Giulia Manzini, Uli Fehrenbach, Timo Alexander Auer, Clarissa Hosse, Daniel Vogele, Disorn Sookthai, Marina Schaaf, Rainer Muche, Axel Hinke, Thomas Seufferlein, Lukas Perkhofer
Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Arndt Stahler, Andreas Jay Kind, Christine Sers, Soulafa Mamlouk, Lothar Müller, Meinolf Karthaus, Stefan Fruehauf, Ullrich Graeven, Ludwig Fischer von Weikersthal, Greta Sommerhäuser, Stefan Kasper, Beeke Hoppe, Annika Kurreck, Swantje Held, Volker Heinemann, David Horst, Armin Jarosch, Sebastian Stinzing, Tanja Trarbach, Dominik Paul Modest
Negative hyperselection of resistance mutations for panitumumab maintenance in RAS wild-type metastatic colorectal cancer (PanaMa phase II trial, AIO KRK 0212). Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Alexander J Ohnmacht, Arndt Stahler, Sebastian Stinzing, Dominik Paul Modest, Julian W Holch, Christoph Benedikt Westphalen, Linus Hölzel, Marisa K Schübel, Ana Galhoz, Ali Farnoud, Minhaz Ud-Dean, Ursula Vehling-Kaiser, Thomas Decker, Markus Moehler, Matthias Heinig, Volker Heinemann, Michael Patrick Menden
The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer. Nature communications 14 (1) (2023)
Arndt Stahler, Beeke Hoppe, Il-Kang Na, Luisa Keilholz, Lothar Müller, Meinolf Karthaus, Stefan Fruehauf, Ullrich Graeven, Ludwig Fischer von Weikersthal, Eray Goekkurt, Stefan Kasper, Andreas Jay Kind, Annika Kurreck, Annabel Helga Sophie Alig, Swantje Held, Anke C Reinacher-Schick, Volker Heinemann, David Horst, Armin Jarosch, Sebastian Stinzing, Tanja Trarbach, Dominik Paul Modest
Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
John H Strickler, Takayuki Yoshino, Kendall Stevinson, Christian Stefan Eichinger, Christina Giannopoulou, Marko Rehn, Dominik Paul Modest
Prevalence of KRAS G12C Mutation and Co-mutations and Associated Clinical Outcomes in Patients With Colorectal Cancer: A Systematic Literature Review. The oncologist (2023)
Greta Sommerhäuser, Meinolf Karthaus, Annika Kurreck, Alexej Ballhausen, Johanna W Meyer-Knees, Stefan Fruehauf, Ullrich Graeven, Lothar Mueller, Alexander O Koenig, Ludwig Fischer V Weikersthal, Eray Goekkurt, Siegfried Haas, Arndt Stahler, Volker Heinemann, Swantje Held, Annabel H S Alig, Stefan Kasper-Virchow, Sebastian Stintzing, Tanja Trarbach, Dominik Paul Modest
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212). International journal of cancer (2023)
Sebastian Stinzing, Kathrin Heinrich, David Tougeron, Dominik Paul Modest, Ingo Schwaner, Jan Eucker, Rudolf Pihusch, Martina Stauch, Florian Kaiser, Christoph A Kahl, Meinolf Karthaus, Christian Müller, Christof Burkart, Anke C Reinacher-Schick, Stefan Kasper-Virchow, Ludwig Fischer von Weikersthal, Beate Krammer-Steiner, Gerald Wolfgang Prager, Gilles Manceau, Volker Heinemann
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF V600E -Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Alexander J Ohnmacht, Arndt Stahler, Sebastian Stinzing, Dominik Paul Modest, Julian W Holch, Christoph Benedikt Westphalen, Linus Hölzel, Marisa K Schübel, Ana Galhoz, Ali Farnoud, Minhaz Ud-Dean, Ursula Vehling-Kaiser, Thomas Decker, Markus Moehler, Matthias Heinig, Volker Heinemann, Michael Patrick Menden
The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer. Nature communications 14 (1) (2023)
Annika Kurreck, Sebastian Stinzing, Dominik Paul Modest
Efficacy, Molecular Biology, Quality of Life, or Economic Aspects: What Do We Really FOCUS oN? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (11) (2022)
G Sommerhäuser, A Kurreck, S Stintzing, V Heinemann, L Fischer von Weikersthal, T Dechow, F Kaiser, M Karthaus, I Schwaner, M Fuchs, A König, C Roderburg, I Hoyer, M Quante, A Kiani, S Fruehauf, L Müller, A Reinacher-Schick, T J Ettrich, A Stahler, Dominik Paul Modest
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer. BMC cancer 22 (1) (2022)
Dominik Paul Modest, Meinolf Karthaus, Stefan Fruehauf, Ullrich Graeven, Lothar Müller, Alexander Otto König, Ludwig Fischer von Weikersthal, Karel Caca, Albrecht Kretzschmar, Eray Goekkurt, Siegfried Haas, Annika Kurreck, Arndt Stahler, Swantje Held, Armin Jarosch, David Horst, Anke C Reinacher-Schick, Stefan Kasper, Volker Heinemann, Sebastian Stinzing, Tanja Trarbach
Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Arndt Stahler, Volker Heinemann, Julian Walter Holch, Jobst Christian von Einem, Christoph Benedikt Westphalen, Kathrin Heinrich, Laura Schlieker, Ivan Jelas, Annabel Helga Sophie Alig, Laura Elisabeth Fischer, Lena Weiss, Dominik Paul Modest, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani, Markus Moehler, Florian Kaiser, Thomas Kirchner, Andreas Jung, Sebastian Stinzing
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE-3). International journal of cancer 149 (11) (2021)
Arndt Stahler, Sebastian Stinzing, Dominik Paul Modest, Ingrid Ricard, Clemens Giessen-Jung, Christine Kapaun, Boryana Ivanova, Florian Kaiser, Ludwig Fischer von Weikersthal, Nicolas Moosmann, Andreas Schalhorn, Martina Stauch, Alexander Kiani, Swantje Held, Thomas Decker, Markus Moehler, Jens Neumann, Thomas Kirchner, Andreas Jung, Volker Heinemann
Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (24) (2020)
A Kurreck, M Geissler, U M Martens, J Riera-Knorrenschild, J Greeve, A Florschütz, S Wessendorf, T Ettrich, S Kanzler, D Nörenberg, M Seidensticker, S Held, P Buechner-Steudel, J Atzpodien, V Heinemann, S Stintzing, T Seufferlein, A Tannapfel, A C Reinacher-Schick, Dominik Paul Modest
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109). Journal of cancer research and clinical oncology 146 (10) (2020)
Dominik Paul Modest, Fernando Rivera, Jean-Baptiste Bachet, Filippo de Braud, Filippo Pietrantonio, Reija Koukakis, Gaston Demonty, Jean-Yves Douillard
Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials. International journal of cancer 145 (2) (2019)
Jobst Christian von Einem, Christine Guenther, Hans-Dieter Volk, Gerald Grütz, Daniela Hirsch, Christoph Salat, Oliver Stoetzer, Peter J Nelson, Marlies Michl, Dominik Paul Modest, Julian Walter Holch, Martin Angele, Christiane Bruns, Hanno Niess, Volker Heinemann
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial. International journal of cancer 145 (6) (2019)